Methicillin-resistant Staphylococcus aureus (MRSA) is a potentially lethal organism in pediatric patients. MRSA is an uncommon otologic pathogen that requires special diagnostic and therapeutic intervention.
Three pediatric patients with community-acquired MRSA otologic infections were identified during 1999.
Tertiary care ear institution.
All patients required intravenous antibiotic therapy to achieve resolution of the infections.
MRSA in children can be community acquired and can cause otitis externa, otitis media with otorrhea, or acute mastoiditis; intravenous therapy that includes vancomycin is necessary for resolution.